Screening tests for renal impairment in patients with type 2 diabetes: The what, when, and how

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The global course of obesity and diabetes presents an alarming forecast for the near future. As the prevalence rates continue to increase and the afflicted population grows younger in age, the associated complications of diabetes will come to pose a greater strain on patients, society, and national health care systems. In recent years, a number of studies have demonstrated the clinical benefits of strict diabetes control in the prevention of debilitating complications, including retinal, renal, and cardiovascular disease. These data highlight the need to maximize our efforts in diabetes prevention and early disease management. Renal dysfunction is a surrogate marker of diabetic microvascular disease, and thus early recognition of renal impairment in patients with diabetes provides an opportunity to modify treatment strategy and improve longterm disease outcomes. This review will summarize methods of assessing renal function and the most recent guidelines for the early screening and diagnosis of diabetic kidney disease.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalPostgraduate Medicine
Volume123
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Type 2 Diabetes Mellitus
Kidney
Retinal Diseases
Diabetic Nephropathies
Diabetes Complications
Disease Management
Early Diagnosis
Cardiovascular Diseases
Obesity
Biomarkers
Guidelines
Delivery of Health Care
Population
Therapeutics

Keywords

  • Kidney disease
  • Nephropathy
  • Renal impairment
  • Screening
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Screening tests for renal impairment in patients with type 2 diabetes : The what, when, and how. / Palmer, Biff F.

In: Postgraduate Medicine, Vol. 123, No. 1, 01.2011, p. 7-14.

Research output: Contribution to journalArticle

@article{374cc2b8164e4a108da348772d246175,
title = "Screening tests for renal impairment in patients with type 2 diabetes: The what, when, and how",
abstract = "The global course of obesity and diabetes presents an alarming forecast for the near future. As the prevalence rates continue to increase and the afflicted population grows younger in age, the associated complications of diabetes will come to pose a greater strain on patients, society, and national health care systems. In recent years, a number of studies have demonstrated the clinical benefits of strict diabetes control in the prevention of debilitating complications, including retinal, renal, and cardiovascular disease. These data highlight the need to maximize our efforts in diabetes prevention and early disease management. Renal dysfunction is a surrogate marker of diabetic microvascular disease, and thus early recognition of renal impairment in patients with diabetes provides an opportunity to modify treatment strategy and improve longterm disease outcomes. This review will summarize methods of assessing renal function and the most recent guidelines for the early screening and diagnosis of diabetic kidney disease.",
keywords = "Kidney disease, Nephropathy, Renal impairment, Screening, Type 2 diabetes",
author = "Palmer, {Biff F.}",
year = "2011",
month = "1",
doi = "10.3810/pgm.2011.01.2240",
language = "English (US)",
volume = "123",
pages = "7--14",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "1",

}

TY - JOUR

T1 - Screening tests for renal impairment in patients with type 2 diabetes

T2 - The what, when, and how

AU - Palmer, Biff F.

PY - 2011/1

Y1 - 2011/1

N2 - The global course of obesity and diabetes presents an alarming forecast for the near future. As the prevalence rates continue to increase and the afflicted population grows younger in age, the associated complications of diabetes will come to pose a greater strain on patients, society, and national health care systems. In recent years, a number of studies have demonstrated the clinical benefits of strict diabetes control in the prevention of debilitating complications, including retinal, renal, and cardiovascular disease. These data highlight the need to maximize our efforts in diabetes prevention and early disease management. Renal dysfunction is a surrogate marker of diabetic microvascular disease, and thus early recognition of renal impairment in patients with diabetes provides an opportunity to modify treatment strategy and improve longterm disease outcomes. This review will summarize methods of assessing renal function and the most recent guidelines for the early screening and diagnosis of diabetic kidney disease.

AB - The global course of obesity and diabetes presents an alarming forecast for the near future. As the prevalence rates continue to increase and the afflicted population grows younger in age, the associated complications of diabetes will come to pose a greater strain on patients, society, and national health care systems. In recent years, a number of studies have demonstrated the clinical benefits of strict diabetes control in the prevention of debilitating complications, including retinal, renal, and cardiovascular disease. These data highlight the need to maximize our efforts in diabetes prevention and early disease management. Renal dysfunction is a surrogate marker of diabetic microvascular disease, and thus early recognition of renal impairment in patients with diabetes provides an opportunity to modify treatment strategy and improve longterm disease outcomes. This review will summarize methods of assessing renal function and the most recent guidelines for the early screening and diagnosis of diabetic kidney disease.

KW - Kidney disease

KW - Nephropathy

KW - Renal impairment

KW - Screening

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=79952788705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952788705&partnerID=8YFLogxK

U2 - 10.3810/pgm.2011.01.2240

DO - 10.3810/pgm.2011.01.2240

M3 - Article

C2 - 21293079

AN - SCOPUS:79952788705

VL - 123

SP - 7

EP - 14

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 1

ER -